Cell and Viral Vector Laboratory Shared Resource

Published Research

Citation Reference Language for Use of the Shared Resource

Example citation: “The Cell and Viral Vector Laboratory Shared Resource services are supported by the Comprehensive Cancer Center of Wake Forest Baptist Medical Center, NCI CCSG P30CA012197 grant.”


Program Key: CPC = Cancer Prevention and Control Program; CRP = Clinical Research Program; TPR = Tumor Progression and Recurrence Program; CBB = Cancer Biology and Biochemistry Program 7457-66.

  1. Xing F, Sharma S, Liu Y, Mo YY, Wu K, Zhang YY, Pochampally R, Martinez LA, Lo HW(TPR), Watabe K(TPR). miR-509 suppresses brain metastasis of breast cancer cells by modulating RhoC and TNF-alpha. Oncogene. 2015;34: 4890-900. PMC4530094.
  2. Maglic D, Stovall DB, Cline M(TPR), Fry EA, Mallakin A, Taneja P, Caudell DL, Willingham MC, Sui G(TPR), Inoue K. DMP1beta, a splice isoform of the tumour suppressor DMP1 locus, induces proliferation and progression of breast cancer. J Pathol. 2015;236(1): 90-102. PMC4398631.
  3. Vallabhaneni KC, Penfornis P, Dhule S, Guillonneau F, Adams KV, Mo YY, Xu R, Liu Y, Watabe K(TPR), Vemuri MC, Pochampally R. Extracellular vesicles from bone marrow mesenchymal stem/stromal cells transport tumor regulatory microRNA, proteins, and metabolites. Oncotarget. 2015;6(7): 4953-67. PMC4467126.
  4. Birbrair A, Zhang T, Wang ZM, Messi ML, Mintz A(CBB), Delbono O. Pericytes at the intersection between tissue regeneration and pathology. Clin Sci (Lond). 2015;128(2): 81-93. PMC4200531.
  5. Hu Y, Mintz A(CBB), Shah SR, Quinones-Hinojosa A, Hsu W(CRP). The FGFR/MEK/ERK/brachyury pathway is critical for chordoma cell growth and survival. Carcinogenesis. 2014;35: 1491-9. PMC4593008.
  6. Westcott MM, Ahmed M, Smedberg JR, Rajani KR, Hiltbold EM, Lyles DS(TPR). Preservation of dendritic cell function during vesicular stomatitis virus infection reflects both intrinsic and acquired mechanisms of resistance to suppression of host gene expression by viral M protein. J Virol. 2013;87(21): 11730-40. PMC3807369.
  7. Wu K, Fukuda K, Xing F, Zhang Y, Sharma S, Liu Y, Chan MD(CRP), Zhou X(TPR), Qasem SA, Pochampally R, Watabe K(TPR), et al. Roles of the cyclooxygenase 2 matrix metalloproteinase 1 pathway in brain metastasis of breast cancer. J Biol Chem. 2015;290(15): 9842-54. PMC4392281.
  8. Liu M, Allegood J, Zhu X, Seo J, Gebre AK, Boudyguina E, Cheng D, Chuang CC, Shelness GS, Spiegel S, Parks JS(TPR). Uncleaved apoM signal peptide is required for formation of large apoM/S1P-enriched HDL particles. J Biol Chem. 2015;290(12): 7861-70. PMC4367285.
  9. Hill TK, Abdulahad A, Kelkar SS, Marini FC(TPR), Long TE, Provenzale JM, Mohs AM(CBB). Indocyanine green-loaded nanoparticles for image-guided tumor surgery. Bioconjug Chem. 2015;26(2): 294-303. PMC4373659.
  10. Westcott MM, Liu J, Rajani K, D'Agostino R, Jr.(CPC), Lyles DS(TPR), Porosnicu M(CRP). IFNbeta and IFNalpha2 differentially protect head and neck cancer cells from VSV-induced oncolysis. J Virol. 2015;89: 7944-54. PMC4505650.
  11. Yu N, Puckett S, Antinozzi PA, Cramer SD, Lyles DS(TPR). Changes in susceptibility to oncolytic vesicular stomatitis virus during progression of prostate cancer. J Virol. 2015;89(10): 5250-63. PMC4442527.
  12. Turner RL, Groitl P, Dobner T, Ornelles DA(TPR). Adenovirus replaces mitotic checkpoint controls. J Virol. 2015;89(9): 5083-96. PMC4403466.
  13. Swanner J, Mims J, Carroll DL(CRP), Akman SA, Furdui CM(CBB), Torti SV, Singh RN(CBB). Differential cytotoxic and radiosensitizing effects of silver nanoparticles on triple-negative breast cancer and non-triple-negative breast cells. Int J Nanomedicine. 2015;10: 3937-53. PMC4501353.
  14. Birbrair A, Zhang T, Wang ZM, Messi ML, Mintz A(CBB), Delbono O. Pericytes: multitasking cells in the regeneration of injured, diseased, and aged skeletal muscle. Front Aging Neurosci. 2014;6: 245. PMC4166895.
  15. Birbrair A, Zhang T, Wang ZM, Messi ML, Olson JD, Mintz A(CBB), Delbono O. Type-2 pericytes participate in normal and tumoral angiogenesis. Am J Physiol Cell Physiol. 2014;307: C25-38. PMC4080181.
  16. Choudhary M, Naczki C, Chen W, Barlow KD, Case LD(CRP), Metheny-Barlow LJ(TPR). Tumor-induced loss of mural Connexin 43 gap junction activity promotes endothelial proliferation. BMC Cancer. 2015;15(1): 427. PMC4464240.
  17. Turner RL, Wilkinson JC, Ornelles DA(TPR). E1B and E4 oncoproteins of adenovirus antagonize the effect of apoptosis inducing factor. Virology. 2014;456-457: 205-19. PMC4044614.
  18. Ornelles DA(TPR), Gooding LR, Garnett-Benson C. Neonatal infection with species C adenoviruses confirmed in viable cord blood lymphocytes. PLoS One. 2015;10(3): e0119256. PMC4357425.
  19. Cook GJ, Caudell DL, Elford HL, Pardee TS(CRP). The efficacy of the ribonucleotide reductase inhibitor didox in preclinical models of AML. Plos One. 2014;9(11): e112619. PMC4234372.
  20. Wadas TJ(CBB), Pandya DN, Solingapuram Sai KK, Mintz A(CBB). Molecular Targeted alpha-particle therapy for oncologic applications. AJR Am J Roentgenol. 2014;203(2): 253-60. PMC4490786.
  21. Gmeiner WH(CBB), Jennings-Gee J, Stuart CH, Pardee TS(CRP). Thymineless death in F10-treated AML cells occurs via lipid raft depletion and Fas/FasL co-localization in the plasma membrane with activation of the extrinsic apoptotic pathway. Leuk Res. 2015;39(2): 229-35. PMC4306618.


Quick Reference

Cell and Viral Vector Laboratory Shared Resource
Dr. Purnima Dubey


Ms. Yelena Karpova


Find A Doctor Ways to Give
Last Updated: 08-05-2016
Comprehensive Cancer Centers National Designation is RenewedMagnet Hospital RecognitionConsumer Choice2015 Best DoctorsJoint Commission Report

Disclaimer: The information on this website is for general informational purposes only and SHOULD NOT be relied upon as a substitute for sound professional medical advice, evaluation or care from your physician or other qualified health care provider.